Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin PK Twice Weekly vs Daily Prophylaxis
NCT02172768Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of micafungin in invasive fungal disease (IFD), sponsored by Radboud University Medical Center. Started Oct 2014; status: completed.
02
Drugs
micafungin
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT02172768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172768.